At the forefront of innovations in health care is personalized medicine. Contrary to the current method of treating each patient in the manner that works best on average, personalized medicine […]
Read MoreADHD White Paper Summary
BiogeniQ, ADHD, Pharmacogenetics
19 November 2018
CADDRA guidelines: The Canadian reference for ADHD
BiogeniQ, ADHD, Pharmacogenetics, Scientific
07 November 2018Attention deficit disorder with or without hyperactivity (ADHD) is often misunderstood and can be difficult to treat. Fortunately, a Canadian not-for-profit organization exists called the […]
Read MoreWhile experts may agree on the genetic causes of attention deficit/hyperactivity disorder (ADD/ADHD), there has been less research on the impact environment can have on this disorder. A number of […]
Read MoreOppositional Defiant disorder (ODD)
Crises, power struggles and negotiation are all too well-known for parents who have a child with oppositional defiant disorder (ODD). However, for those who are not familiar with this disorder: […]
Read MoreEvery year, when school exams are finally over, thousands of parents with an AD/HD child (with or without hyperactivity) ask themselves the same question: should we stop our child’s medication […]
Read MoreWhy stimulate an already-stimulated child?
When your child has attention-deficit/hyperactivity disorder, the last thing you want to hear is your doctor recommending you give her a stimulant. Most likely, you think she’s already stimulated […]
Read MoreAt BiogeniQ, we are committed to provide you with your genetic information in the most complete and easiest way possible.
Read MoreADHD, or attention deficit/hyperactivity disorder, is a neurological disorder whose major effect is to impede an individual from being able to modulate their thoughts. Overall, it affects between […]
Read More